220 related articles for article (PubMed ID: 21865135)
1. Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.
Gómez-Martín C; Concha A; Corominas JM; García-Caballero T; García-García E; Iglesias M; López JA; Ramón y Cajal S; Rojo F; Palacios J; Vera-Sempere F; Aranda E; Colomer R; García-Alfonso P; Garrido P; Rivera F; López-Ríos F; ;
Clin Transl Oncol; 2011 Sep; 13(9):636-51. PubMed ID: 21865135
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
García-Alfonso P; Salazar R; García-Foncillas J; Musulén E; García-Carbonero R; Payá A; Pérez-Segura P; Ramón y Cajal S; Navarro S; ;
Clin Transl Oncol; 2012 Oct; 14(10):726-39. PubMed ID: 22855150
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
Albanell J; Andreu X; Calasanz MJ; Concha A; Corominas JM; García-Caballero T; López JA; López-Ríos F; Ramón y Cajal S; Vera-Sempere FJ; Colomer R; Martín M; Alba E; González-Martín A; Llombart A; Lluch A; Palacios J
Clin Transl Oncol; 2009 Jun; 11(6):363-75. PubMed ID: 19531451
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).
Garrido P; de Castro J; Concha Á; Felip E; Isla D; López-Ríos F; Paz-Ares L; Ramírez J; Sanz J; Gómez JJ
Clin Transl Oncol; 2012 May; 14(5):338-49. PubMed ID: 22551539
[TBL] [Abstract][Full Text] [Related]
5. HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Committee.
Wong NACS; Amary F; Butler R; Byers R; Gonzalez D; Haynes HR; Ilyas M; Salto-Tellez M; Taniere P
J Clin Pathol; 2018 May; 71(5):388-394. PubMed ID: 29439009
[TBL] [Abstract][Full Text] [Related]
6. [Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
López-Ríos F; Paz-Ares L; Sanz J; Isla D; Pijuan L; Felip E; Gómez-Román JJ; de Castro J; Conde E; Garrido P
Rev Esp Patol; 2020; 53(3):167-181. PubMed ID: 32650968
[TBL] [Abstract][Full Text] [Related]
7. HER2 in gastric cancer: a biomarker with clinical impact, but not without translational challenges.
Lordick F
Clin Transl Oncol; 2011 Sep; 13(9):597-8. PubMed ID: 21865130
[No Abstract] [Full Text] [Related]
8. Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Alfonso P; García-Foncillas J; Salazar R; Pérez-Segura P; García-Carbonero R; Musulén-Palet E; Cuatrecasas M; Landolfi S; Ramón Y Cajal S; Navarro S; ;
Clin Transl Oncol; 2015 Apr; 17(4):264-73. PubMed ID: 25373533
[TBL] [Abstract][Full Text] [Related]
9. The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.
Isla Casado D; González-Martín A; Alba Conejo E
Clin Transl Oncol; 2010 Nov; 12(11):707-8. PubMed ID: 20974559
[No Abstract] [Full Text] [Related]
10. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract][Full Text] [Related]
11. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.
Bartley AN; Washington MK; Ventura CB; Ismaila N; Colasacco C; Benson AB; Carrato A; Gulley ML; Jain D; Kakar S; Mackay HJ; Streutker C; Tang L; Troxell M; Ajani JA
Arch Pathol Lab Med; 2016 Dec; 140(12):1345-1363. PubMed ID: 27841667
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X; ;
Clin Transl Oncol; 2014 Mar; 16(3):243-56. PubMed ID: 23749327
[TBL] [Abstract][Full Text] [Related]
13. [New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Isla D; Lozano MD; Paz-Ares L; Salas C; de Castro J; Conde E; Felip E; Gómez-Román J; Garrido P; Belén Enguita A
Rev Esp Patol; 2023; 56(2):97-112. PubMed ID: 37061248
[TBL] [Abstract][Full Text] [Related]
14. Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Garrido P; Conde E; de Castro J; Gómez-Román JJ; Felip E; Pijuan L; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2020 Jul; 22(7):989-1003. PubMed ID: 31598903
[TBL] [Abstract][Full Text] [Related]
15. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
[TBL] [Abstract][Full Text] [Related]
16. SEOM clinical guidelines for the treatment of early breast cancer.
del Barco Berrón S; Ciruelos Gil E; Tusquets Trías de Bes I; Muñoz Mateu M; Sánchez Rovira P; Rodríguez Lescure Á; Isla Casado D;
Clin Transl Oncol; 2010 Nov; 12(11):711-8. PubMed ID: 20974561
[TBL] [Abstract][Full Text] [Related]
17. [HER2 testing in gastric cancer - results of a German expert meeting].
Lordick F; Al-Batran SE; Hofheinz RD; Lorenzen S; Thuss-Patience P; Baretton GB; Dietel M; Gaiser T; Kirchner T; Kreipe HH; Quaas A; Röcken C; Rüschoff J; Tannapfel A
Z Gastroenterol; 2016 Aug; 54(8):791-6. PubMed ID: 27529529
[TBL] [Abstract][Full Text] [Related]
18. Seom guidelines for the treatment of gastric cancer 2015.
Martin-Richard M; Custodio A; García-Girón C; Grávalos C; Gomez C; Jimenez-Fonseca P; Manzano JL; Pericay C; Rivera F; Carrato A
Clin Transl Oncol; 2015 Dec; 17(12):996-1004. PubMed ID: 26691658
[TBL] [Abstract][Full Text] [Related]
19. SEOM clinical guidelines: a consolidated project.
Cruz Hernández JJ; Rodríguez CA
Clin Transl Oncol; 2012 Jul; 14(7):489-90. PubMed ID: 22721791
[No Abstract] [Full Text] [Related]
20. SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma.
Rivera F; Grávalos C; García-Carbonero R;
Clin Transl Oncol; 2012 Jul; 14(7):528-35. PubMed ID: 22721798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
